Switching to Biosimilars in Inflammatory Rheumatic Conditions: Current Knowledge

Switching to Biosimilars in Inflammatory Rheumatic Conditions: Current Knowledge

Biosimilars are more affordable versions of previously approved biopharmaceuticals that are designed to reduce healthcare expenditure and increase patient access to this therapeutic class. To achieve their economic potential, many European countries have started to switch patients from reference dru...

Full description

Bibliographic Details
Main Authors: Filipe C. Araújo, Joao Eurico Fonseca, Joao Goncalves
Format: Article
Language:English
Published: European Medical Journal 2018-07-01
Series:European Medical Journal Rheumatology
Subjects:
Biosimilar
immunogenicity
interchangeability
non-medical switch
rheumatoid arthritis (RA)
rheumatic disease
Online Access:https://www.emjreviews.com/rheumatology/article/switching-to-biosimilars-in-inflammatory-rheumatic-conditions-current-knowledge/

Internet

https://www.emjreviews.com/rheumatology/article/switching-to-biosimilars-in-inflammatory-rheumatic-conditions-current-knowledge/

Similar Items